Adagene-adr logo

Adagene-adr Share Price (NASDAQ: ADAG)

$2.18

-0.19

(-8.02%)

Live

Last updated on

Check the interactive Adagene-adr Stock chart to analyse performance

Adagene-adr stock performance

as on August 27, 2025 at 11:28 pm IST

  • Today's Low:$2.17
    Today's High:$2.24

    Day's Volatility :3.13%

  • 52 Weeks Low:$1.33
    52 Weeks High:$3.58

    52 Weeks Volatility :63.0%

Adagene-adr Stock Returns

PeriodAdagene Inc-adrSector (Health Care)Index (Russel 2000)
3 Months
22.7%
3.7%
0.0%
6 Months
14.65%
-6.9%
0.0%
1 Year
-24.58%
-11.9%
0.0%
3 Years
52.35%
7.7%
-6.9%

Adagene Inc-adr Key Stats

Check Adagene-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.37
Open
$2.38
Today's High
$2.24
Today's Low
$2.17
Market Capitalization
$112.6M
Today's Volume
$72.9K
52 Week High
$3.5807
52 Week Low
$1.325
Revenue TTM
$103.2K
EBITDA
$-32.8M
Earnings Per Share (EPS)
$-0.63
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.26%

Stock Returns calculator for Adagene-adr Stock including INR - Dollar returns

The Adagene-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Adagene-adr investment value today

Current value as on today

₹77,098

Returns

₹22,902

(-22.9%)

Returns from Adagene-adr Stock

₹27,575 (-27.57%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Adagene-adr Stock

7%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Adagene-adr Stock from India on INDmoney has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Adagene Inc-adr

  • Name

    Holdings %

  • General Atlantic Llc

    8.12%

  • SC China Holding Ltd

    2.85%

  • FMR Inc

    2.51%

  • Mill Creek Capital Advisors LLC

    0.42%

  • Kamunting Street Cap Management, L.p.

    0.27%

  • Barclays PLC

    0.26%

Analyst Recommendation on Adagene-adr Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Adagene-adr(by analysts ranked 0 to 5 stars)

Adagene-adr Share Price Target

What analysts predicted

Upside of 342.32%

Target:

$9.64

Current:

$2.18

Adagene-adr share price target is $9.64, a slight Upside of 342.32% compared to current price of $2.18 as per analysts' prediction.

Adagene-adr Stock Insights

  • Price Movement

    In the last 7 days, ADAG stock has moved up by 9.7%
  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 8.64M → 103.20K (in $), with an average decrease of 42.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -24.91M → -13.51M (in $), with an average increase of 84.4% per quarter
  • ADAG vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 85.6%
  • ADAG vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 52.9%
  • Price to Sales

    ForADAG every $1 of sales, investors are willing to pay $1135.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.

Adagene Inc-adr Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$103.2K
↓ 99.43%
Net Income
$-33.4M
↑ 76.41%
Net Profit Margin
-32.4K%
↓ 32281.84%

Adagene-adr Technicals Summary

Sell

Neutral

Buy

Adagene-adr is currently in a neutral trading position according to technical analysis indicators.

Adagene Inc-adr Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Adagene Inc-adr logo
14.08%
14.65%
-24.58%
52.35%
-83.99%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.9%
-51.12%
-0.89%
-2.51%
Beone Medicines Ltd logo
4.54%
18.87%
52.28%
84.02%
26.72%
Vertex Pharmaceuticals Incorporated logo
-16.02%
-19.22%
-19.42%
37.43%
43.36%
Alnylam Pharmaceuticals, Inc. logo
38.9%
84.99%
60.96%
115.82%
243.29%

About Adagene Inc-adr

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. The company was incorporated in 2011 and is headquartered in Suzhou, China.
Organization
Adagene-adr
Employees
138
CEO
Dr. Peter P. Luo Ph.D.
Industry
Healthcare

Key Management of Adagene Inc-adr

NameTitle
Dr. Peter P. Luo Ph.D.
Co- Founder, Chairman, CEO and President of R&D
Mr. Man Kin Tam M.B.A.
CFO & Director
Ms. Ling Zhou
Executive Director & Head of Human Resources
Dr. Qinghai Zhao Ph.D.
Chief Manufacturing Officer
Ms. Yan Li M.B.A.
Senior Vice President of Bioinformatics & Information Technology
Ms. Xiaohong She
Senior VP & Head of Clinical Operations
Dr. Guizhong Liu Ph.D.
Senior Vice President of Early Drug Discovery
Mr. Alexander Goergen
VP & Head of Business Development
Dr. Jiping Zha M.D., Ph.D.
Executive Vice President of Clinical Development
Dr. Songmao Zheng Ph.D.
Senior VP of Clinical Pharmacology & Quantitative Sciences

Important FAQs about investing in ADAG Stock from India :

What is Adagene-adr share price today?

Adagene-adr share price today is $2.18 as on . Adagene-adr share today touched a day high of $2.24 and a low of $2.17.

What is the 52 week high and 52 week low for Adagene-adr share?

Adagene-adr share touched a 52 week high of $3.58 and a 52 week low of $1.33. Adagene-adr stock price today i.e. is trending at $2.18, lower by 39.12% versus the 52 week high.

How to invest in Adagene-adr Stock (ADAG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adagene-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adagene-adr Shares that will get you 0.6881 shares as per Adagene-adr share price of $2.18 per share as on August 27, 2025 at 11:28 pm IST.

What is the minimum amount required to buy Adagene-adr Stock (ADAG) from India?

Indian investors can start investing in Adagene-adr (ADAG) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Adagene-adr stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Adagene-adr share’s latest price of $2.18 as on August 27, 2025 at 11:28 pm IST, you will get 4.5872 shares of Adagene-adr. Learn more about fractional shares .

What are the returns that Adagene-adr has given to Indian investors in the last 5 years?

Adagene-adr stock has given -83.99% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More